Profusa, Inc.

Profusa, Inc., trading under the ticker NVAC, is a medical-technology company operating in the implantable biosensor space, focused on developing tissue-integrating sensors for continuous physiological monitoring. The company filed a 10-Q quarterly report with the SEC on May 17, 2023, under accession number 0001213900-23-040837, reflecting its reporting obligations as a public entity. Profusa's platform targets the healthcare and diagnostics sector, with applications in continuous glucose and metabolic monitoring. The filing captures a snapshot of the company's financial position as it navigated the post-SPAC public-company landscape. Sign up for full data, filings, and deal analytics on SpacDesk.